INQR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INQR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
InnovaQor's average Accounts Receivable for the three months ended in Sep. 2023 was $0.06 Mil. InnovaQor's Revenue for the three months ended in Sep. 2023 was $0.15 Mil. Hence, InnovaQor's Days Sales Outstanding for the three months ended in Sep. 2023 was 34.22.
The historical rank and industry rank for InnovaQor's Days Sales Outstanding or its related term are showing as below:
During the past 8 years, InnovaQor's highest Days Sales Outstanding was 68.69. The lowest was 3.54. And the median was 50.27.
InnovaQor's Days Sales Outstanding declined from Sep. 2022 (65.51) to Sep. 2023 (34.22).
The historical data trend for InnovaQor's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovaQor Annual Data | |||||||||||||||||
Trend | Jun02 | Jun03 | Jun04 | Jun05 | Jun06 | Jun07 | Dec21 | Dec22 | |||||||||
Days Sales Outstanding | Get a 7-Day Free Trial | - | 3.54 | 68.69 | 63.82 | 36.71 |
InnovaQor Quarterly Data | ||||||||||||||||||||
Sep05 | Dec05 | Mar06 | Jun06 | Sep06 | Dec06 | Mar07 | Jun07 | Sep07 | Dec07 | Mar08 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 65.51 | 55.97 | 19.70 | 28.90 | 34.22 |
For the Health Information Services subindustry, InnovaQor's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, InnovaQor's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where InnovaQor's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
InnovaQor's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as
Days Sales Outstanding (A: Dec. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2021 ) | + | Accounts Receivable (A: Dec. 2022 )) | / | count ) | / | Revenue (A: Dec. 2022 ) | * | Days in Period |
= | ( (0.033 | + | 0.036) | / | 2 ) | / | 0.343 | * | 365 |
= | 0.0345 | / | 0.343 | * | 365 | ||||
= | 36.71 |
InnovaQor's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:
Days Sales Outstanding (Q: Sep. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Jun. 2023 ) | + | Accounts Receivable (A: Sep. 2023 )) | / | count ) | / | Revenue (A: Sep. 2023 ) | * | Days in Period |
= | ( (0.081 | + | 0.033) | / | 2 ) | / | 0.152 | * | 365 / 4 |
= | 0.057 | / | 0.152 | * | 365 / 4 | ||||
= | 34.22 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovaQor (OTCPK:INQR) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of InnovaQor's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Francisco Iii Roca | director | 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401 |
Darrell L Peterson | director, officer: Chief Executive Officer | 2390 CIRCLE DRIVE, WEST PALM BEACH FL 33406 |
Sharon Lynne Hollis | director | 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401 |
Justin Doherty | director | 400 S. AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401 |
Thomas Joseph Bellante | officer: Chief Financial Officer | 14706 CROYDON PLACE, TAMPA FL 33618 |
Jayne Kirby | officer: VP Finance | 1035 LAURIER O., SUITE 200, MONTREAL A8 H2V 2L1 |
Arthur Gelston | 10 percent owner | 1035 LAURIER STREET WEST, MONTREAL A8 H2V 2L1 |
Visual Healthcare Corp | 10 percent owner | 790 ROCKLAND AVE., MONTREAL, QC. A8 H2V 2Z6 |
Philippe Rainville | officer: CFO | 391A LAURIER WEST, MONTREAL A8 H2V 2K3 |
Philippe Panzini | director | 391A LAURIER WEST, MONTREAL A8 H2V 2K3 |
Michel Maksud | officer: VP Technology | 391A LAURIER WEST, MONTREAL A8 H2V 2K3 |
Gerard Dab | director, officer: CEO and Chairman of the Board | 391A LAURIER WEST, MONTREAL A8 H2V 2K3 |
Louis J Lombardo | director | 108 SMITH LAKE ROAD, ROSCOE NY 12776 |
Visualmed Clinical Systems Corp | 10 percent owner | |
Barry Scharf | officer: VP Operations | 391A LAURIER WEST, MONTREAL A8 H2V 2K3 |
From GuruFocus
By Marketwired Marketwired • 06-03-2021
By Marketwired Marketwired • 06-28-2021
By Marketwired Marketwired • 10-12-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.